Study guide
3.3 Hematologic Malignancies
AMT Medical Laboratory Scientist Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: General Laboratory Operations, Safety & Quality
1.1 Laboratory Safety, OSHA Standards, Hazard Communication, and Biohazard Control 1.2 Quality Systems, Quality Control, and Westgard Rules Interpretation 1.3 Specimen Collection, Handling, Order of Draw, and Phlebotomy Complications 1.4 Laboratory Instrumentation, Photometry, Spectrophotometry, and Centrifugation 1.5 Laboratory Mathematics, Dilutions, Solution Preparation, and Standard Curves 1.6 Regulatory Compliance, CLIA '88 Regulations, Accreditation, and Laboratory Ethics
2 Chapter 2: Clinical Chemistry & Metabolic Testing
2.1 Carbohydrate Metabolism, Glucose Regulation, Diabetes Mellitus, and HbA1c 2.2 Proteins, Non-Protein Nitrogenous Compounds (BUN, Creatinine, Uric Acid), and Renal Function 2.3 Enzymology and Organ Systems 2.4 Electrolytes, Acid-Base Balance, Anion Gap, and Blood Gas Analysis 2.5 Clinical Endocrinology, Thyroid, Adrenal, and Reproductive Hormones 2.6 Clinical Toxicology, Therapeutic Drug Monitoring (TDM), and Pharmacokinetics 2.7 Lipids, Lipoproteins, and the Friedewald LDL Calculation
3 Chapter 3: Hematology & Leukocyte Disorders
3.1 RBC Indices and Anemia 3.2 WBC Differential and Benign Disorders 3.3 Hematologic Malignancies 3.4 Hemoglobin Structure, Hemoglobinopathies (Sickle Cell, Thalassemia), and Variants 3.5 Hematology Automation, Flow Cytometry, and Cell Counting Technology
4 Chapter 4: Coagulation & Hemostasis
4.1 Primary and Secondary Hemostasis, Platelet Function, and Vascular Integrity 4.2 Coagulation Cascade Disorders 4.3 Coagulation Testing and Anticoagulants
5 Chapter 5: Immunology & Serology
5.1 Immune Mechanisms, Hypersensitivity Reactions, and Autoimmune Disease Testing 5.2 Serological Testing Principles and Infectious Serology
6 Chapter 6: Immunohematology & Blood Grouping
6.1 ABO and Rh Blood Group Systems, Antigens, Subgroups, and Weak D Variant 6.2 Red Cell Antibody Screening, Identification Panels, and Dosage Effects 6.3 Direct and Indirect Antiglobulin Testing (DAT/IAT) and Troubleshooting 6.4 Compatibility Testing, Crossmatching, and Hemolytic Disease of the Fetus and Newborn
7 Chapter 7: Blood Banking & Transfusion Medicine
7.1 Blood Donor Selection, Screening, Collection, and Component Storage 7.2 Transfusion Practice, Indications for Blood Components, and Administration 7.3 Transfusion Reactions: Investigation Protocol and Reaction Classification
8 Chapter 8: Clinical Microbiology
8.1 Specimen Processing, Gram Stain, and Aerobic Gram-Positive Cocci 8.2 Gram-Negative Bacilli: Enterobacteriaceae, Non-Fermenters, and Fastidious Organisms 8.3 Anaerobic Bacteria, Mycobacteria, Acid-Fast Stains, and Molecular Diagnostic Methods 8.4 Clinical Mycology and Medical Parasitology 8.5 Antimicrobial Susceptibility Testing, Resistance, and Virology
9 Chapter 9: Urinalysis & Body Fluids
9.1 Physical and Chemical Examination of Urine and Reagent Strip Principles 9.2 Microscopic Urinalysis: Cells, Casts, Crystals, and Renal Pathology 9.3 Analysis of Cerebrospinal Fluid (CSF), Serous Fluids, and Synovial Fluid
3.3 Hematologic Malignancies
Key Takeaways Explain This Topic AI
Acute Leukemias (AML, ALL) present with >20% blasts in the bone marrow, rapid onset, and prominent pancytopenia.
Auer rods are fused primary granules found only in myeloblasts (AML), never in lymphoblasts (ALL).
Chronic Myeloid Leukemia (CML) is defined by the Philadelphia chromosome [t(9;22)], which creates the BCR-ABL1 fusion gene.
Chronic Lymphocytic Leukemia (CLL) is a mature B-cell neoplasm characterized by absolute lymphocytosis and fragile 'smudge cells' on the smear.
Myeloproliferative Neoplasms (MPNs), such as Polycythemia Vera and Essential Thrombocythemia, involve the overproduction of one or more mature myeloid cell lines.
Last updated: July 2026
3.3 Hematologic Malignancies
Hematologic malignancies represent clonal disorders of hematopoietic stem cells or their downstream progeny. The broad classification divides these diseases into leukemias (originating in the bone marrow and circulating in blood) and lymphomas (originating in discrete lymphoid tissue masses). For the MLS exam, the focus is heavily on classifying leukemias and myeloproliferative neoplasms.
Acute vs. Chronic Leukemias
The fundamental difference between acute and chronic leukemia lies in the maturation stage of the malignant clone and the clinical progression.
- Feature Acute Leukemia Chronic Leukemia
- Predominant Cell Blasts and immature precursors Mature-appearing cells
- Bone Marrow Blasts ≥ 20% (WHO criteria) Typically < 10%
- Clinical Onset Sudden, aggressive Insidious, slowly progressive
- Patient Age All ages (ALL in kids, AML in adults) Typically adults / elderly
- Cytopenias Severe (anemia, thrombocytopenia) Mild to none early on
- Acute Leukemias
Acute leukemias involve a block in differentiation; cells proliferate but fail to mature, leading to an accumulation of blasts that crowd out normal marrow elements (causing anemia, bleeding, and infection).
Acute Myeloid Leukemia (AML)
AML is the most common acute leukemia in adults. It involves the malignant proliferation of myeloid blasts (myeloblasts, monoblasts, erythroblasts, or megakaryoblasts).
Key Morphological Feature: Auer rods . These are needle-like or rod-like inclusions in the cytoplasm of blasts, representing fused primary (azurophilic) granules. Auer rods are pathognomonic for the myeloid lineage; they are NEVER seen in lymphoid blasts.
Cytochemistry: Positive for Myeloperoxidase (MPO) and Sudan Black B (SBB).
Important Subtype (APL): Acute Promyelocytic Leukemia (APL) is characterized by a t(15;17) translocation and bundled Auer rods (faggot cells). It frequently causes severe Disseminated Intravascular Coagulation (DIC) and is uniquely treated with all-trans retinoic acid (ATRA).
Acute Lymphoblastic Leukemia (ALL)
ALL is the most common childhood malignancy. It arises from lymphoid precursors.
Morphology: Lymphoblasts are small to medium-sized with scant cytoplasm, inconspicuous nucleoli, and no granules.
Classification: Divided into B-ALL and T-ALL. B-ALL accounts for the vast majority. T-ALL often presents in adolescent males as a large mediastinal (thymic) mass.
Cytochemistry: Negative for MPO and SBB. Positive for Periodic Acid-Schiff (PAS) in block-like patterns, and positive for Terminal Deoxynucleotidyl Transferase (TdT).
Chronic Leukemias
Chronic leukemias involve the proliferation of well-differentiated, mature cells.
Chronic Myeloid Leukemia (CML)
CML is a Myeloproliferative Neoplasm characterized by an extreme overproduction of the granulocytic series.
Genetics: Defined by the Philadelphia (Ph) chromosome , a reciprocal translocation between chromosomes 9 and 22— t(9;22) . This creates the BCR-ABL1 fusion gene, which codes for a constitutively active tyrosine kinase driving unchecked cell division.
Peripheral Smear: Shows a massive leukocytosis (often >100 x 10^9/L) featuring the entire spectrum of myeloid maturation (from myeloblasts to segmented neutrophils). Basophilia and eosinophilia are prominent and highly suspicious for CML.
Distinguishing CML from Leukemoid Reaction: A leukemoid reaction (severe infection) mimics CML. To differentiate, CML has a low Leukocyte Alkaline Phosphatase (LAP) score, while a leukemoid reaction has a high LAP score.
Chronic Lymphocytic Leukemia (CLL)
CLL is the most common leukemia in adults in Western countries. It is an indolent neoplasm of mature, functionally incompetent B-lymphocytes.
Peripheral Smear: Marked absolute lymphocytosis. The cells appear as small, mature lymphocytes with hyper-condensed "soccer ball" chromatin.
Diagnostic Hallmark: Smudge cells . The neoplastic B-cells are abnormally fragile and rupture during the physical process of making the blood smear. (Note: Adding a drop of albumin to the blood before smearing can prevent this artifact).
Complications: Often leads to hypogammaglobulinemia (increasing infection risk) or Autoimmune Hemolytic Anemia (AIHA).
Myeloproliferative Neoplasms (MPNs)
MPNs are a group of clonal disorders characterized by the excess proliferation of one or more mature myeloid cell lines (erythrocytes, granulocytes, platelets). CML is a primary member. The others are heavily linked to the JAK2 V617F mutation .
Polycythemia Vera (PV): Unregulated proliferation of erythrocytes (high RBC count, high Hgb/Hct), independent of EPO. EPO levels are typically very low. Patients present with hyperviscosity, thrombosis, and intense itching after a hot shower.
Essential Thrombocythemia (ET): Proliferation primarily of megakaryocytes leading to extreme thrombocytosis (platelet count often > 1,000 x 10^9/L). Characterized by giant platelets and thrombotic/bleeding complications.
Primary Myelofibrosis (PMF): Excessive proliferation of megakaryocytes and granulocytes, which release cytokines (like PDGF) that stimulate fibroblasts to produce massive amounts of collagen in the marrow.
Peripheral Smear: Classic teardrop cells (dacrocytes) form as RBCs squeeze through the fibrotic marrow. Leukoerythroblastosis (immature RBCs and WBCs in circulation) is common.